1 |
Abbasi S, Azimi C, Othman F (2009). Risk factors for breast cancer in Iranian women: a case control study. Inter J Cancer Res, 5, 1-11.
DOI
|
2 |
Ahmad M (2003). Risk factors for breast cancer among women attending breast clinic in University Malaya Medical Centre Kuala Lumpur. NCD Malaysia, 2, 23-31.
|
3 |
Clamp A, Danson S, Clemons M (2003). Hormonal and genetic risk factors for breast cancer. The Surgeon, 1, 23-31.
DOI
ScienceOn
|
4 |
Coopman CP, Mueller SC (2006). Mini review: the SYK tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett, 241, 159-73.
DOI
ScienceOn
|
5 |
Coopman PJP, Do MTH, Barth M, et al (2000). The SYK tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature, 406, 742-7.
DOI
ScienceOn
|
6 |
Harrison AP, Srinivasan K, Binu, VS, et al (2010). Risk factors for breast cancer among women attending a tertiary care hospital in southern India. Inter J Collaborative Res on Internal Medicine & Public Health, 2, 109-16.
|
7 |
Hu YH, Nagata C, Shimizu H, et al (1997). Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan. Breast Cancer Res Treat, 43, 65-72.
DOI
ScienceOn
|
8 |
Hunter S, Sato N, Kim MK, et al (2000). Structural requirements of SYK kinase for Fcgamma receptor-mediated phagocytosis. Exp Hematol, 27, 875-84.
|
9 |
Inayat U, Kayani MA, Rani F (2012). Sporadic mutation and expressional analysis of spleen tyrosine kinase gene in breast cancer. Pol J Pathol, 2, 106-11.
|
10 |
Jemal A, Bray F, Melissa M (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
DOI
|
11 |
Kanwal S, Kayani MA, Faryal R (2012). Identification of novel SNPs in SYK gene of breast cancer patients: computational analysis of SNPs in the 50UTR. Mol Biol Rep, 39, 8345-51.
DOI
ScienceOn
|
12 |
Kruk J (2007). Association of lifestyle and other risk factors with breast cancer according to menopausal status: a case-control study in the region of Western Pomerania (Poland). Asian Pac J Cancer Prev, 8, 513-24.
|
13 |
Lakhani SR, Collins N, Sloane JP, et al (1995). Loss of heterozygosity in lobular carcinoma in situ of the breast. J Clin Pathol Mol Pathol, 48, 74-8.
DOI
|
14 |
Latour S, Zhang J, Siraganian RP, et al (1998). A unique insert in the linker domain of SYK is necessary for its function in immunoreceptor signalling. EMBO J, 17, 2584-95.
DOI
ScienceOn
|
15 |
Liu BA, Jablonowski K, Raina M, et al (2006). The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol Cell, 22, 851-68.
DOI
ScienceOn
|
16 |
Mahjabeen I, Baig RM, Masood N, et al (2012). Genetic variations in XRCC1 gene in sporadic head and neck cancer (HNC) patients. Pathol Oncol Res, 10, 9567.
|
17 |
Mc Pherson K, Stell CM, Dixon JM (2000). Breast cancerepidemiology, risk factors, and genetics. Br Med J, 321, 624-8.
DOI
ScienceOn
|
18 |
Osborne C, Wilson P, Tripathy D (2004). Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist, 9, 361-77.
DOI
|
19 |
Minami Y, Ohuchi N, Fukao A (1997). Risk factors for breast cancer: a case-control study of screen-detected breast cancer Miyagi Prefecture, Japan. Breast Cancer Res Treat, 44, 225-33.
DOI
ScienceOn
|
20 |
Naeem N, Nasir A, Aman Z, et al (2008). Frequency of HER-2/NEU receptor positivity and its association with other features of breast cancer. J Ayub Med Coll Abbottabad, 20, 23-6.
|
21 |
de Castro RO (2011). Regulation and Function of SYK Tyrosine Kinase in Mast Cell Signaling and Beyond. J Signal Transduction, 10, 507291.
|
22 |
Toyama T, Iwase H, Yamashita H, et al (2002). Reduced expression of the SYK gene is correlated with poor prognosis in human breast cancer. Cancer, 189, 97-102.
|
23 |
Wang L, Duke L, Zhang PS, et al (2003). Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res, 63, 4724-30.
|
24 |
Yuan Y, Mendez R, Sahin A, et al (2001). Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res, 61, 5558-61.
|